Kinzeno Triple Action Massage Gel: A Revolutionary Launch in Natural Pain Relief and Wellness






JUPITER, FL, UNITED STATES, May 27, 2026 — Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage biopharmaceutical company developing investigational therapies for neurodegenerative diseases, today announced that patient enrollment is now underway in its Phase 2a RESET clinical trial (NCT07592767)…




